Related Experiment Videos
The Danish Endometrial Cancer Study (DEMCA)
1Department of Oncology, Odense University Hospital, Denmark.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1989
Summary
The Danish Endometrial Cancer (DEMCA) group developed nationwide guidelines for endometrial cancer management. Protocols aim to reserve adjuvant irradiation for high-risk stage I patients, with preliminary data collection underway.
Area of Science:
- Gynecologic Oncology
- Clinical Trial Management
Background:
- Endometrial cancer treatment varied, necessitating standardized national guidelines.
- Adjuvant irradiation in stage I endometrial cancer was often used broadly, prompting a need for risk stratification.
Purpose of the Study:
- To establish uniform, nationwide guidelines for all stages of endometrial cancer.
- To restrict adjuvant irradiation in stage I disease to high-risk patients.
- To evaluate sequential endocrine therapy for stage IV endometrial cancer and recurrences.
Main Methods:
- Development of the Danish Endometrial Cancer (DEMCA) group protocols.
- Implementation of protocols for newly diagnosed endometrial cancer patients since September 1986.
- Inclusion of histologic grading and myometrial invasion assessment for risk stratification.
Main Results:
- Preliminary data from the first year of study implementation are available.
- The majority of Danish women with newly diagnosed endometrial cancer were treated under these protocols.
- Mean follow-up is currently insufficient for treatment outcome analysis.
Conclusions:
- The DEMCA protocols provide a framework for standardized endometrial cancer management.
- Risk stratification using histologic factors is central to the protocol design.
- Further follow-up is required to assess the efficacy of the implemented protocols.